Whither amnesty? Uncertainty in US antitrust enforcement
Since its formalisation in 1993, the corporate leniency policy of the US Department of Justice’s Antitrust Division has achieved remarkable results. Companies that discovered anti-competitive behaviour in their ranks rushed to report their wrongdoing to the Antitrust Division, hoping to be first in the door and thereby receive near-certain amnesty for the company and all co-operating employees. There was reason to hurry. The twin hallmarks of the policy — transparency and predictability — provided assurance that those who lost the race for leniency were almost always subject to criminal penalties.
But a strange thing happened on the way to record corporate fines and hefty jail sentences for individual violators: the wave of recent enforcement actions against LIBOR-submitting banks brought with it a destabilising undertow of new realities, and the clear all-or-nothing incentives gave way to complexity. A successful leniency applicant may still be exposed to significant criminal penalties from other law enforcement or regulatory agencies, diluting the obvious benefits of being first in, while increasing the potential risks. At the same time, a co-operating late-comer, which ordinarily would not qualify for leniency, may still be able to avoid criminal penalties.
Thus, for companies weighing whether or not to report possible US antitrust violations, these cases and other developments have replaced clear incentives for being first in the door with newfound uncertainty. While these trends thus far have been confined to antitrust enforcement in the banking and financial services industry, the animating factors suggest the possibility of similar outcomes in other highly regulated and concentrated sectors…
If you are registered and logged in to the site, click on the link below to read the rest of the Allen & Overy briefing. If not, please register or sign in with your details below.
News from Allen & Overy
News from The Lawyer
Briefings from Allen & Overy
Money purchase deconstructed: working with the new definition — a checklist for trustees and administrators
The definition of money purchase benefits is changing, as are the rules on how schemes are required to deal with any benefit that becomes classified as a ‘non-money purchase’.
Despite the progress that has been made towards launching the European unitary patent system and the Unified Patent Court, Spain continues to actively oppose the changes.
Analysis from The Lawyer
At the time of its launch Accutrainee was described as a revolutionary change to the training model. Has it proved to be so? Not really.
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.